These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12687489)

  • 1. Enzymatic synthesis of chiral intermediates for pharmaceuticals.
    Patel R; Hanson R; Goswami A; Nanduri V; Banerjee A; Donovan MJ; Goldberg S; Johnston R; Brzozowski D; Tully T; Howell J; Cazzulino D; Ko R
    J Ind Microbiol Biotechnol; 2003 May; 30(5):252-9. PubMed ID: 12687489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biocatalytic synthesis of intermediates for the synthesis of chiral drug substances.
    Patel RN
    Curr Opin Biotechnol; 2001 Dec; 12(6):587-604. PubMed ID: 11849941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbial/enzymatic synthesis of chiral pharmaceutical intermediates.
    Patel RN
    Curr Opin Drug Discov Devel; 2003 Nov; 6(6):902-20. PubMed ID: 14758760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial/enzymatic synthesis of chiral drug intermediates.
    Patel RN
    Adv Appl Microbiol; 2000; 47():33-78. PubMed ID: 12876794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biocatalysis: synthesis of chiral intermediates for drugs.
    Patel RN
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):741-64. PubMed ID: 17117684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemo-enzymatic synthesis of pharmaceutical intermediates.
    Patel RN
    Expert Opin Drug Discov; 2008 Feb; 3(2):187-245. PubMed ID: 23480222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biocatalysis for synthesis of pharmaceuticals.
    Patel RN
    Bioorg Med Chem; 2018 Apr; 26(7):1252-1274. PubMed ID: 28648492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of potent N1-substituted indole melatonin receptor agonists.
    Tsotinis A; Eleutheriades A; Hough K; Sugden D
    Chem Commun (Camb); 2003 Feb; (3):382-3. PubMed ID: 12613623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of melatonin receptors agonists and antagonists.
    Tarzia G; Diamantini G; Mor M; Spadoni G
    Farmaco; 2000 Mar; 55(3):184-7. PubMed ID: 10919077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-[N-Acylamino(C1-C3)alkyl]indoles as MT1 melatonin receptor partial agonists, antagonists, and putative inverse agonists.
    Spadoni G; Balsamini C; Bedini A; Diamantini G; Di Giacomo B; Tontini A; Tarzia G; Mor M; Plazzi PV; Rivara S; Nonno R; Pannacci M; Lucini V; Fraschini F; Stankov BM
    J Med Chem; 1998 Sep; 41(19):3624-34. PubMed ID: 9733487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biocatalytic synthesis of chiral alcohols and amino acids for development of pharmaceuticals.
    Patel RN
    Biomolecules; 2013 Oct; 3(4):741-77. PubMed ID: 24970190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesizing Chiral Drug Intermediates by Biocatalysis.
    Jiang W; Fang B
    Appl Biochem Biotechnol; 2020 Sep; 192(1):146-179. PubMed ID: 32323141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping the melatonin receptor. 5. Melatonin agonists and antagonists derived from tetrahydrocyclopent[b]indoles, tetrahydrocarbazoles and hexahydrocyclohept[b]indoles.
    Davies DJ; Garratt PJ; Tocher DA; Vonhoff S; Davies J; Teh MT; Sugden D
    J Med Chem; 1998 Feb; 41(4):451-67. PubMed ID: 9484496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GR196429: a nonindolic agonist at high-affinity melatonin receptors.
    Beresford IJ; Browning C; Starkey SJ; Brown J; Foord SM; Coughlan J; North PC; Dubocovich ML; Hagan RM
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1239-45. PubMed ID: 9618428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the vasoconstrictor action of melatonin and putative melatonin receptor ligands in the tail artery of juvenile Wistar rats.
    Ting KN; Dunn WR; Davies DJ; Sugden D; Delagrange P; Guardiola-Lemaître B; Scalbert E; Wilson VG
    Br J Pharmacol; 1997 Dec; 122(7):1299-306. PubMed ID: 9421275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of chiral C3- and C4-units by microbial enzymes.
    Shimizu S; Kataoka M
    Adv Biochem Eng Biotechnol; 1999; 63():109-23. PubMed ID: 9933983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indanyl piperazines as melatonergic MT2 selective agents.
    Mattson RJ; Catt JD; Keavy D; Sloan CP; Epperson J; Gao Q; Hodges DB; Iben L; Mahle CD; Ryan E; Yocca FD
    Bioorg Med Chem Lett; 2003 Mar; 13(6):1199-202. PubMed ID: 12643943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacophoric search and 3D-QSAR comparative molecular field analysis studies on agonists of melatonin sheep receptors.
    Marot C; Chavatte P; Morin-Allory L; Viaud MC; Guillaumet G; Renard P; Lesieur D; Michel A
    J Med Chem; 1998 Nov; 41(23):4453-65. PubMed ID: 9804685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin receptor agents: synthesis, resolution by HPLC on polysaccharides chiral stationary phases, absolute configuration, and pharmacology of the enantiomers of (+/-)-N-[[2[(7-fluoro-1,2,3,4-tetrahydronaphthalen-1-yl)ethyl]acetamide.
    Lipka-Belloli E; Guelzim A; Yous S; Lefebvre J; Descamps-Francois C; Capet F; Vaccher C
    Chirality; 2001 May; 13(4):199-206. PubMed ID: 11284025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Industrial biotransformations in the synthesis of building blocks leading to enantiopure drugs.
    Muñoz Solano D; Hoyos P; Hernáiz MJ; Alcántara AR; Sánchez-Montero JM
    Bioresour Technol; 2012 Jul; 115():196-207. PubMed ID: 22230779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.